Internal Medicine, Infectious Disease · Pittsburgh, PA
NPI
1205209517
Since 2015
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
420 E North Ave Ste 406
Pittsburgh, PA, 15212
Phone (412) 359-3683
Groups this clinician bills Medicare through
Medicare paid, 2024
$39K
531 services
Medicare patients, 2024
226
Average age 70
Drug cost, 2024
$216K
1,149 prescriptions
Company payments, 2025
$53.49
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michelle Paulson was code 99232 (hospital e&m - subsequent), 257 times for 83 patients. In total Michelle Paulson billed 531 services in 11 codes, and Medicare paid $39K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-09-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 257 | 83 | $61.21 | $16K |
| 99213 Office E&M - Established | Office | 104 | 87 | $61.39 | $6,384 |
| 99222 Hospital E&M - Initial | Facility | 73 | 70 | $100.87 | $7,363 |
| 99214 Office E&M - Established | Office | 60 | 48 | $96.36 | $5,781 |
| 99204 Office E&M - New | Office | 15 | 15 | $115.57 | $1,734 |
By year: 2022 $24K for 406 services; 2023 $29K for 481 services; 2024 $39K for 531 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michelle Paulson prescribed most often to Medicare patients was Doxycycline Hyclate, with 139 prescriptions and refills. In total Michelle Paulson wrote 1,149 Medicare prescriptions that cost $216K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Doxycycline Hyclate Generic | 139 | 311 | 48 | $4,955 |
| Amoxicillin Generic | 99 | 220 | 38 | $1,723 |
| Cefadroxil Generic | 94 | 186 | 36 | $7,413 |
| Cephalexin Generic | 90 | 220 | 28 | $2,698 |
| Vancomycin Hcl Generic | 59 | 61 | 19 | $5,661 |
| Zerbaxa Ceftolozane/Tazobactam | 48 | 48 | Under 11 | $83K |
| Imipenem-Cilastatin Sodium Imipenem/Cilastatin Sodium | 40 | 40 | Under 11 | $21K |
| Azithromycin Generic | 36 | 92 | 15 | $870 |
| Ampicillin-Sulbactam Ampicillin Sod/Sulbactam Sod | 35 | 35 | Under 11 | $2,033 |
| Cefazolin Sodium Generic | 35 | 35 | Under 11 | $944 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 33 | 69 | 19 | $1,178 |
| Penicillin V Potassium Generic | 32 | 47 | Under 11 | $610 |
| Rifampin Generic | 29 | 71 | 15 | $2,116 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 29 | 59 | Under 11 | $346 |
| Ceftriaxone Ceftriaxone Sodium | 29 | 29 | Under 11 | $686 |
Brand drugs: 57 claims; generic drugs: 1,092 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michelle Paulson $53.49 ($53.49 in general payments such as food, travel and fees) from 2 companies. The largest payer was Axsome Therapeutics, Inc. with $35.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.